A Mobile App for Self-management of Urgency and Mixed Urinary Incontinence in Women: Randomized Controlled Trial.
Towe Wadensten, Emma Nyström, Karin Franzén...
https://pubmed.ncbi.nlm.nih.gov/33818395/Actively Recruiting
Led by Umeå University · Updated on 2025-06-26
60
Participants Needed
1
Research Sites
N/A
Total Duration
This observational study focuses on women aged 18 and older diagnosed with urgency or mixed urinary incontinence who have received a medical evaluation and first-line treatment recommendation. It evaluates the use and effectiveness of the Te4taeII app following contact with ordinary healthcare. Researchers aim to determine whether treatment via this app is effective and feasible after primary care. Participants will use the Te4taeII app for 15 weeks to manage their urinary incontinence. The app provides education on pelvic floor and urinary incontinence, bladder training, pelvic floor muscle exercises, and psychoeducation. It includes features like reminders, exercise visualization, and feedback on symptom changes. Access to the app requires a one-time activation code provided after study inclusion. Women will complete online questionnaires before starting treatment, after 15 weeks, and one year later to assess symptoms, quality of life, and improvement. These include validated tools like the ICIQ-UI SF and ICIQ-LUTSqol. The study collects data on app usability, satisfaction, and desire for further treatment. Follow-up is conducted digitally, and the primary outcome is the symptom score change from start to 15 weeks.
CONDITIONS
Implementation of the App Tät®II for Treatment of Urgency and Mixed Urinary Incontinence
A
Annelie Olofsson, MD, PhD
E
Emma Nyström, MD, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Umeå University
Lead Sponsor
Region Jämtland Härjedalen
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 digital screening visit (video meeting) plus online questionnaires
Duration - 15 weeks
Participants use the Tät®II app for self-guided treatment of urgency or mixed urinary incontinence.
App use at participant's convenience with remote support via email
Duration - Up to 1 year after treatment
Participants complete digital follow-up questionnaires assessing symptoms, quality of life, and impression of improvement.
2 digital questionnaire assessments at 15 weeks and 1 year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Towe Wadensten, Emma Nyström, Karin Franzén...
https://pubmed.ncbi.nlm.nih.gov/33818395/Towe Wadensten, Emma Nyström, Malin Sjöström...
https://pubmed.ncbi.nlm.nih.gov/38141064/Towe Wadensten, Emma Nyström, Anneli Nord...
https://pubmed.ncbi.nlm.nih.gov/35266189/Umeå University
Lead Sponsor
Region Jämtland Härjedalen
Collaborating Sponsor